title: Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?
authors.affiliation: Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT.
authors.forename: Purvi
authors.initials: P
authors.lastname: Parwani
authors.forename: Jason
authors.initials: J
authors.lastname: Ryan
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy* / Q000453:epidemiology*; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D018377:Neurotransmitter Agents